Trial intelligence / Profile preview

Local desmopressin before functional endoscopic sinus surgery for chronic rhinosinusitis

IRCT20130713013976N5Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Aug 2017
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, double-blind trial of desmopressin in chronic rhinosinusitis (CRS) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Amount of blood volume, Visual field of surgery and 1 more. Started Aug 2017; status: completed.

02

Drugs

desmopressin
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on IRCT20130713013976N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130713013976N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call